Literature DB >> 15296961

The potential of lipid emulsion for ocular delivery of lipophilic drugs.

Shunmugaperumal Tamilvanan1, Simon Benita.   

Abstract

For nearly a decade, oil-in-water lipid emulsions containing either anionic or cationic droplets have been recognized as an interesting and promising ocular topical delivery vehicle for lipophilic drugs. The aim of this review is to present the potential of lipid emulsions for ocular delivery of lipophilic drugs. The review covers an update on the state of the art of incorporating the lipophilic drugs, a brief description concerning the components and the classification of lipid emulsions. The ocular fate following topical instillation, safety evaluation experiments and the applications of lipid emulsions are thoroughly discussed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15296961     DOI: 10.1016/j.ejpb.2004.03.033

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  22 in total

1.  Stability assessment of injectable castor oil-based nano-sized emulsion containing cationic droplets stabilized by poloxamer-chitosan emulsifier films.

Authors:  S Tamilvanan; B Ajith Kumar; S R Senthilkumar; Raj Baskar; T Raja Sekharan
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

2.  Niosome-encapsulated gentamicin for ophthalmic controlled delivery.

Authors:  Ghada Abdelbary; Nashwa El-Gendy
Journal:  AAPS PharmSciTech       Date:  2008-06-18       Impact factor: 3.246

3.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

4.  Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.

Authors:  Hussein O Ammar; H A Salama; M Ghorab; A A Mahmoud
Journal:  AAPS PharmSciTech       Date:  2009-06-18       Impact factor: 3.246

5.  Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation.

Authors:  Seyedeh Negin Kassaee; Mohammad Mehdi Mahboobian
Journal:  Drug Deliv Transl Res       Date:  2021-02-11       Impact factor: 4.617

6.  Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.

Authors:  Sophia K Mirza; Sandra M Johnson
Journal:  Clin Ophthalmol       Date:  2010-08-09

7.  Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

Authors:  Frederic Lallemand; Philippe Daull; Simon Benita; Ronald Buggage; Jean-Sebastien Garrigue
Journal:  J Drug Deliv       Date:  2012-02-27

8.  Enzymatic synthesis and self-assembly of glycolipids: robust self-healing and wound closure performance of assembled soft materials.

Authors:  Yadavali Siva Prasad; Balasubramani Saritha; Ayyapillai Tamizhanban; Krishnamoorthy Lalitha; Sakthivel Kabilan; C Uma Maheswari; Vellaisamy Sridharan; Subbiah Nagarajan
Journal:  RSC Adv       Date:  2018-11-05       Impact factor: 4.036

9.  Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay.

Authors:  Hong Liang; Christophe Baudouin; Marie-Odile Faure; Grégory Lambert; Françoise Brignole-Baudouin
Journal:  Mol Vis       Date:  2009-08-25       Impact factor: 2.367

10.  Formulation optimization of a palm-based nanoemulsion system containing levodopa.

Authors:  Syafinaz Zainol; Mahiran Basri; Hamidon Bin Basri; Ahmad Fuad Shamsuddin; Siti Salwa Abdul-Gani; Roghayeh Abedi Karjiban; Emilia Abdul-Malek
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.